179 related articles for article (PubMed ID: 25942345)
21. The role of macrophage migration inhibitory factor in autoimmune liver disease.
Assis DN; Leng L; Du X; Zhang CK; Grieb G; Merk M; Garcia AB; McCrann C; Chapiro J; Meinhardt A; Mizue Y; Nikolic-Paterson DJ; Bernhagen J; Kaplan MM; Zhao H; Boyer JL; Bucala R
Hepatology; 2014 Feb; 59(2):580-91. PubMed ID: 23913513
[TBL] [Abstract][Full Text] [Related]
22. Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.
Kimkong I; Nakkuntod J; Sae-Ngow S; Snabboon T; Avihingsanon Y; Hirankarn N
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):229-35. PubMed ID: 22053592
[TBL] [Abstract][Full Text] [Related]
23. Tumour necrosis factor alpha (TNF-α) genetic polymorphisms and the risk of autoimmune liver disease: a meta-analysis.
Li S; Huang X; Zhong H; Chen Z; Peng Q; Deng Y; Qin X
J Genet; 2013 Dec; 92(3):617-28. PubMed ID: 24371186
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil.
Bittencourt PL; Palácios SA; Cançado EL; Porta G; Carrilho FJ; Laudanna AA; Kalil J; Goldberg AC
Am J Gastroenterol; 2003 Jul; 98(7):1616-20. PubMed ID: 12873588
[TBL] [Abstract][Full Text] [Related]
25. The CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to asthma: a meta-analysis.
Lee YH; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2012 Aug; 39(8):8525-32. PubMed ID: 22707194
[TBL] [Abstract][Full Text] [Related]
26. CTLA-4 exon 1 +49 polymorphism alone and in a haplotype with -318 promoter polymorphism may confer susceptibility to chronic HBV infection in Chinese Han patients.
Duan S; Zhang G; Han Q; Li Z; Liu Z; Chen J; Lv Y; Li N; Wang Y; Li M; Lou S; Yang M; Zhu Q; Xing F
Mol Biol Rep; 2011 Nov; 38(8):5125-32. PubMed ID: 21161390
[TBL] [Abstract][Full Text] [Related]
27. The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto's thyroiditis in Asian but not Caucasian populations: an updated meta-analysis.
Feng M; Zhang FB; Deng HR
Endocrine; 2013 Oct; 44(2):350-8. PubMed ID: 23860622
[TBL] [Abstract][Full Text] [Related]
28. Association between cytotoxic T-lymphocyte-associated antigen 4 +49A/G polymorphism and persistent hepatitis B virus infection in the Asian population: evidence from the current studies.
Huang R; Hao Y; Fan Y; Yang C; Wu K; Cao S; Wu C
Genet Test Mol Biomarkers; 2013 Aug; 17(8):601-6. PubMed ID: 23725008
[TBL] [Abstract][Full Text] [Related]
29. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.
Song GG; Kim JH; Lee YH
Mol Biol Rep; 2013 Apr; 40(4):2985-93. PubMed ID: 23264102
[TBL] [Abstract][Full Text] [Related]
30. Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1?
Coss Adame E; Granados J; Uribe M; Torre A
Ann Hepatol; 2011; 10(1):28-32. PubMed ID: 21301006
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients.
Aiba Y; Nakamura M; Joshita S; Inamine T; Komori A; Yoshizawa K; Umemura T; Horie H; Migita K; Yatsuhashi H; Nakamuta M; Fukushima N; Saoshiro T; Hayashi S; Kouno H; Ota H; Muro T; Watanabe Y; Nakamura Y; Komeda T; Shimada M; Masaki N; Komatsu T; Yagura M; Sugi K; Koga M; Tsukamoto K; Tanaka E; Ishibashi H;
J Gastroenterol; 2011 Oct; 46(10):1203-12. PubMed ID: 21594562
[TBL] [Abstract][Full Text] [Related]
32. Association between the CTLA-4 +49A/G polymorphism and type 1 diabetes: a meta-analysis.
Si X; Zhang X; Luo Y; Tang W
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1336-42. PubMed ID: 23009570
[TBL] [Abstract][Full Text] [Related]
33. Analysis of major histocompatibility complex and CTLA-4 alleles in Brazilian patients with primary biliary cirrhosis.
Bittencourt PL; Palácios SA; Farias AQ; Abrantes-Lemos CP; Cançado EL; Carrilho FJ; Laudanna AA; Kalil J; Goldberg AC
J Gastroenterol Hepatol; 2003 Sep; 18(9):1061-6. PubMed ID: 12911663
[TBL] [Abstract][Full Text] [Related]
34. [Genetic association of tumor necrosis factor (TNF)-alpha polymorphisms with primary biliary cirrhosis and autoimmune liver diseases in a Chinese population].
Fan LY; Zhong RQ; Tu XQ; Pfeiffer T; Feltens R; Zhu Y; Zhou L
Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):160-2. PubMed ID: 15059302
[TBL] [Abstract][Full Text] [Related]
35. Possible association of cytotoxic T lymphocyte antigen-4 genetic polymorphism with liver damage of primary biliary cirrhosis in Japan.
Kanno Y; Rai T; Monoe K; Saito H; Takahashi A; Irisawa A; Ohira H
Fukushima J Med Sci; 2006 Dec; 52(2):79-85. PubMed ID: 17427759
[TBL] [Abstract][Full Text] [Related]
36. Association of CTLA-4 variants with susceptibility to inflammatory bowel disease: a meta-analysis.
Zhang M; Ni J; Xu WD; Wen PF; Qiu LJ; Wang XS; Pan HF; Ye DQ
Hum Immunol; 2014 Mar; 75(3):227-33. PubMed ID: 24374044
[TBL] [Abstract][Full Text] [Related]
37. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis.
Juran BD; Atkinson EJ; Schlicht EM; Fridley BL; Petersen GM; Lazaridis KN
Hepatology; 2008 Feb; 47(2):563-70. PubMed ID: 18041714
[TBL] [Abstract][Full Text] [Related]
38. Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.
Zhao HY; Duan HX; Gu Y
Clin Transl Oncol; 2014 Oct; 16(10):879-85. PubMed ID: 24493286
[TBL] [Abstract][Full Text] [Related]
39. Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients.
Joshita S; Umemura T; Yoshizawa K; Katsuyama Y; Tanaka E; Nakamura M; Ishibashi H; Ota M;
J Hepatol; 2010 Sep; 53(3):537-41. PubMed ID: 20557968
[TBL] [Abstract][Full Text] [Related]
40. Fas polymorphisms influence susceptibility to autoimmune hepatitis.
Hiraide A; Imazeki F; Yokosuka O; Kanda T; Kojima H; Fukai K; Suzuki Y; Hata A; Saisho H
Am J Gastroenterol; 2005 Jun; 100(6):1322-9. PubMed ID: 15929764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
